Refinement of TSLP expression mediates chronic allodynia associated with IL22/STAT3 axis

Chun-Ching Lu1, Ying-Yi Lu2, Hung-Pei Tsai3

  • 1Department of Orthopaedics and Traumatology, National Yang Ming Chiao Tung University Hospital, Yilan, 260006, Taiwan; Department of Orthopaedics, School of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.

PubMed
Summary

Targeting thymic stromal lymphopoietin (TSLP) offers a novel approach to treating chronic pain conditions like allodynia. Inhibiting TSLP reduces neuroinflammation and neuronal loss, potentially alleviating pain by modulating the IL22/STAT3 pathway.